Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 2.4.2.4 extracted from

  • Puglisi, F.; Cardellino, G.G.; Crivellari, D.; Di Loreto, C.; Magri, M.D.; Minisini, A.M.; Mansutti, M.; Andreetta, C.; Russo, S.; Lombardi, D.; Perin, T.; Damante, G.; Veronesi, A.
    Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancer (2008), Ann. Oncol., 19, 1541-1546.
    View publication on PubMed
Search for more literature for 2.4.2.4

Application

Application Comment Organism
medicine immunhistochemical evaluation of thymidine phosphorylase expression is a promising predictor of therapeutic benefit from docetaxel-modulated capecitabine for metastatic breast cancer Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
-
-

Source Tissue

Source Tissue Comment Organism Textmining
breast adenocarcinoma cell
-
 Homo sapiens
-

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
5'-deoxy-5-fluorouridine + phosphate
-
 Homo sapiens 5-fluorouracil + 5-deoxy-D-ribose 1-phosphate
-
 ?